M. Kleinberger, D. Cifci, C. Paiato, E. Tomasich, M. Mair, A. Steindl, Z. Carrero, L. Berchtold, J. Hainfellner, L. Müllauer, G. Heller, M. Preusser, J. Kather, A. Berghoff
{"title":"192P Analysis of tumor-associated macrophages and tumor-infiltrating lymphocytes within the tumor microenvironment of primary tumors and matched brain metastases","authors":"M. Kleinberger, D. Cifci, C. Paiato, E. Tomasich, M. Mair, A. Steindl, Z. Carrero, L. Berchtold, J. Hainfellner, L. Müllauer, G. Heller, M. Preusser, J. Kather, A. Berghoff","doi":"10.1016/j.iotech.2023.100651","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100651","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138618868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A.T.L. Verbiest, D. Delombaerde, M. Verhaert, L. Tack, C.L. Oeste, L. Cool, L. Croes, I. Bassez, D.F.E. Hens, C. Franssen, S. Aspeslagh, V. Geldhof, P.R. Debruyne, C. Vulsteke
{"title":"114P Real-world insights on pan-cancer immune checkpoint inhibitor treatment: Initial findings of a Belgian multicenter study","authors":"A.T.L. Verbiest, D. Delombaerde, M. Verhaert, L. Tack, C.L. Oeste, L. Cool, L. Croes, I. Bassez, D.F.E. Hens, C. Franssen, S. Aspeslagh, V. Geldhof, P.R. Debruyne, C. Vulsteke","doi":"10.1016/j.iotech.2023.100586","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100586","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"167 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138621407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Katagihallimath, R. Nandishaiah, S. Sharma, S. Venkatesan, R. Rao, N. Bharatham, M. Gupta, D. Kundu, H. K. Kotakonda, R. R. Kalainesan, S. Reddy, B. Tewary, S. Muley, A. Gangoli, P. C. Uthappa, L. Maitreyi, B. Venkatraman, S. Datta, S. V. R. Sody, B. Majumder, S. Hameed
{"title":"152P Discovery of best-in-class dual-acting A2AR/A2BR antagonists that are functional in high adenosine environment","authors":"N. Katagihallimath, R. Nandishaiah, S. Sharma, S. Venkatesan, R. Rao, N. Bharatham, M. Gupta, D. Kundu, H. K. Kotakonda, R. R. Kalainesan, S. Reddy, B. Tewary, S. Muley, A. Gangoli, P. C. Uthappa, L. Maitreyi, B. Venkatraman, S. Datta, S. V. R. Sody, B. Majumder, S. Hameed","doi":"10.1016/j.iotech.2023.100663","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100663","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"77 s330","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138622054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"104P Bladder-sparing treatment for muscle-invasive bladder carcinoma (MIBC): A single-center, single-arm clinical study of sequential neoadjuvant chemotherapy followed by tislelizumab neoadjuvant immunotherapy","authors":"Y. Zeng","doi":"10.1016/j.iotech.2023.100576","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100576","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"84 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138623427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
W. Fang, Y. Yang, Y. Huang, Y. Zhao, Y. Zhang, T. Zhou, G. Chen, S. Zhao, Y. Ma, S. Hong, H. Zhao, L. Zhang
{"title":"124P Surufatinib plus toripalimab combined with etoposide (E) and cisplatin (P) in patients (pts) with advanced naive small cell lung cancer (SCLC): Updated results of a phase Ib/II trial","authors":"W. Fang, Y. Yang, Y. Huang, Y. Zhao, Y. Zhang, T. Zhou, G. Chen, S. Zhao, Y. Ma, S. Hong, H. Zhao, L. Zhang","doi":"10.1016/j.iotech.2023.100596","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100596","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"21 38‐39","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138624889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L.C.G.F. Palhares, J. Chauhan, M. Grandits, P. Romero-Clavijo, R. Gitsaki-Taylor, S. Mele, S.N. Karagiannis, H. Bax
{"title":"141P An IgE antibody targeting the melanoma-associated chondroitin sulfate proteoglycan 4","authors":"L.C.G.F. Palhares, J. Chauhan, M. Grandits, P. Romero-Clavijo, R. Gitsaki-Taylor, S. Mele, S.N. Karagiannis, H. Bax","doi":"10.1016/j.iotech.2023.100613","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100613","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"24 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138625124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. van Cutsem, M. Fakih, N.H. Segal, B. Johnson, A. Kardosh, A. Philipovskiy, S. Krishnamurthi, P.J. Gold, J. Dekervel, B. L. Schlechter, J. Grossman, M.E. Elez Fernandez, N. Vardiashvili, A.A. Azambuja, C. Eng, M.P. Ducreux, T. André, J. Tabernero, H.J. Lenz, M. Hidalgo
{"title":"116TiP Randomized, open-label, phase II study of botensilimab (BOT) alone and in combination with balstilimab (BAL) versus standard-of-care in patients with refractory metastatic colorectal cancer","authors":"E. van Cutsem, M. Fakih, N.H. Segal, B. Johnson, A. Kardosh, A. Philipovskiy, S. Krishnamurthi, P.J. Gold, J. Dekervel, B. L. Schlechter, J. Grossman, M.E. Elez Fernandez, N. Vardiashvili, A.A. Azambuja, C. Eng, M.P. Ducreux, T. André, J. Tabernero, H.J. Lenz, M. Hidalgo","doi":"10.1016/j.iotech.2023.100588","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100588","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"101 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138609104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Davar, J.G. Knecht, A. Vandross, C.A. Perez, D.M. Miller, J. Powderly, A. Bessudo, K. Montazeri, M.J. Mooradian, A. Gupta, E. Patel, D. Fantini, S. Paramasivan, D. Crowe, M. Duncan, S. Uptain, K. Luptakova, R. Sullivan
{"title":"133P Phase I/II study of XTX101: A masked, tumor-activated Fc-enhanced anti-CTLA-4, in patients with advanced solid tumors","authors":"D. Davar, J.G. Knecht, A. Vandross, C.A. Perez, D.M. Miller, J. Powderly, A. Bessudo, K. Montazeri, M.J. Mooradian, A. Gupta, E. Patel, D. Fantini, S. Paramasivan, D. Crowe, M. Duncan, S. Uptain, K. Luptakova, R. Sullivan","doi":"10.1016/j.iotech.2023.100605","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100605","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138613746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J.D.S. Vieira, V. Voltarelli, M.T. Amano, A.A. Camargo, P.C. Brum
{"title":"201P Role of aerobic exercise training on the mitochondrial metabolism and effector function of CD8+ tumor-infiltrating lymphocytes","authors":"J.D.S. Vieira, V. Voltarelli, M.T. Amano, A.A. Camargo, P.C. Brum","doi":"10.1016/j.iotech.2023.100677","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100677","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138616399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Celsa, G. Cabibbo, T.U. Marron, A. Saeed, M. Pinter, Y-H. Huang, A. Pillai, M. Schoenlein, J. von Felden, P. Galle, M. Kudo, L. Rimassa, A. Singal, H. Chon, W-F. Hsu, L. Brunetti, C. Pinto, M. Bersanelli, A. Cortellini, D. Pinato
{"title":"111P Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma compared to patients with advanced solid tumours","authors":"C. Celsa, G. Cabibbo, T.U. Marron, A. Saeed, M. Pinter, Y-H. Huang, A. Pillai, M. Schoenlein, J. von Felden, P. Galle, M. Kudo, L. Rimassa, A. Singal, H. Chon, W-F. Hsu, L. Brunetti, C. Pinto, M. Bersanelli, A. Cortellini, D. Pinato","doi":"10.1016/j.iotech.2023.100583","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100583","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138617871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
